A judge has expanded a freezing order over assets owned by Forum Finance director Vincenzo Tesoriero to include property outside Australia, including a yacht in Miami dubbed âXOXOâ, after Westpac raised concerns about non-disclosure.
7-Eleven has told a court it is willing to negotiate a deal with Seven over the 7NOW logo, a trade mark the TV network recently lost after a successful challenge by the convenience store chain.
US machinery manufacturer Caterpillar has won its appeal of a decision approving sportswear brand Pumaâs ‘Procat’ trade mark application, with a judge finding âa significant numberâ of consumers might be confused by the mark.
A former Norton Rose Fulbright partner locked in a six-year legal battle with the firm has urged the Full Court to allow a $160,000 damages award in his favour to be recalculated, saying it did not provide enough “sting”, amounting to just $1,500 per partner.
The Commonwealth Bank of Australia has slammed an attempt by a class action to âtrawl throughâ its Chief Executive Officerâs emails in search of correspondence regarding it decision to rebate commissions grandfathered by the Future of Financial Advice reforms.
National Australia Bank has been hit with a $18.5 million fine after admitting to allegations by ASIC that it failed to adequately disclose its adviser fees for five years.
In a recent decision, the Full Federal Court confirmed that a trade mark owner who merely authorises use of its trade mark cannot be subject to liability for direct trade mark infringement under section 120(1) of the Trade Marks Act, writes Shelston IP’s Kathy Mytton and Sean McManis.
A judge overseeing a Papua New Guinean politicianâs defamation lawsuit has criticised Nineâs refusal to take down two allegedly defamatory articles ahead of a delayed trial, saying there was no reason to keep them online except for the publisherâs âpride or egoâ.
A judge has reopened the trial in Hells Angels’ trade mark case against Melbourne-based retailer Redbubble to hear allegations by the bikie gang that the online marketplace was still selling infringing products after the July hearing wrapped up.
Swiss pharmaceutical company Biogen is seeking a court order blocking an Australian generic drug manufacturer from selling a cheap multiple sclerosis drug it claims infringes its patent for medicine Tecfidera, a court has heard.